ALETA BIOTHERAPEUTICS INC has a total of 58 patent applications. It increased the IP activity by 1350.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are BLUEFIN BIOMEDICINE INC, ISU ABXIS CO LTD and CSPC DOPHEN CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Australia | 6 | |
#4 | Brazil | 5 | |
#5 | Canada | 5 | |
#6 | China | 5 | |
#7 | EPO (European Patent Office) | 5 | |
#8 | Republic of Korea | 5 | |
#9 | Chile | 4 | |
#10 | Israel | 4 | |
#11 | Mexico | 4 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Rennert Paul | 46 |
#2 | Lobb Roy | 45 |
#3 | Roy Lobb | 9 |
#4 | Hackel Benjamin | 7 |
#5 | Klesmith Justin | 7 |
#6 | Paul Rennert | 6 |
#7 | John Todd Schiller | 1 |
#8 | Schiller John Todd | 1 |
#9 | Rennert Paul David | 1 |
#10 | Paul David Rennert | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020219989A1 | Compositions and methods for treatment of cancer | |
WO2020113063A1 | Single domain antibodies against cll-1 | |
CN111936158A | CD19 variants | |
KR20200003367A | Cancer Treatment Compositions and Methods | |
BR112019017401A2 | compositions and methods for tumor transduction | |
AU2016343809A1 | Compositions and methods for treatment of cancer | |
BR112018008390A2 | compositions and methods for tumor transduction |